Latest News of BIVI
BioVie Inc. (BIVI) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
1 month ago
BioVie's terlipressin liquid formulation patent approved in Japan, securing its place in the US, India, and Chile. The stable formulation benefits patients with cirrhosis and ascites, providing a sign...
Individual investors invested in BioVie Inc. (NASDAQ:BIVI) copped the brunt of last week's US$55m market cap decline
By Yahoo! Finance |
3 months ago
Individual investors own a significant portion of BioVie Inc. (NASDAQ:BIVI) with 49% ownership, experiencing high losses as market cap fell. Institutional investors and insiders also hold shares, with...